Cyclosporin a in resistant demyelinating polyradiculoneuropathy

Muscle and Nerve

Volumn 21, Issue 4, 1998, Pages 454-460

  Barnett, Michael H ^a   Pollard, John D ^a   Davies, Llewelyn ^a   McLeod, James G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Cyclosporin; Disability status; Immunosuppression; Nephrotoxicity

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DEMYELINATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; POLYRADICULITIS; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME; CHRONIC DISEASE; CLINICAL TRIAL; DEMYELINATING DISEASE; DRUG RESISTANCE; HOSPITALIZATION; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; POLYRADICULONEUROPATHY; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ADULT; AGED; CHRONIC DISEASE; CYCLOSPORINE; DEMYELINATING DISEASES; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032037807     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8     Document Type: Article

References (20)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991;41:617-618.
2. Asbury AK, Arnason BG, Adams RD: The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215.
3. Bishop GA, Hall BM: Effects of immunosuppressive drugs on functions of activated T lymphocytes. Transplantation 1988;45:967-972.
4. Cross AH, Cannella B, Brosnan CF, Raine CS: Homing to central nervous system vasculature by antigen-specific lymphocytes. Lab Invest 1990;63:162-170.
5. Dalakas MC, Engel WK: Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981;9:134-145.
6. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, Swanson C: Plasma exchange in chronic inflammalory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461-465.
7. Dyck PJ, Lais AC, Ohta M Bastron JA, Okazaki H, Groover RV: Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
8. Dyck PJ, O'Brien P, Swanson C, Low P, Daube J: Combined azathioprine and prednisone in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1985;314:461-465.
9. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ: Prednisone improves chronic inflammatory demyelinating polyra-diculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
10. Dyck PJ, Prineas JW, Pollard JD: Chronic inflammatory demyelinating polyradiculoneuropathy, in Dyck PJ, Thomas PK, Griffin J, Low PA, Poduslo J (eds): Peripheral Neuropathy, 3rd ed. Philadelphia, Saunders, 1993, pp 1498-1517.
11. Faulds D, Goa KL, Benfield P: Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
12. Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L: Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol 1991;238:75-79.
13. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW: Immune attack on the Schrann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-636.
14. Hodgkinson SJ, Pollard JD, McLeod JG: Cyclosporin A in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 1990;53:327-330.
15. Hughes RAC, Gray IA, Gregson NA, Kadlubowski M: Immune responses to myelin antigens in Guillain-Barré syndrome. J Neuroimmunol 1984;6:303-312.
16. Ilyas AA, Mithen FA, Chen ZW, Cook SD: AntiGMl IgA antibodies in Guillain-Barré syndrome. J Neuroimmunol 1992;36: 69-76.
17. Ilyas AA, Mithen FA, Chen ZW, Cook SD: Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J Neurol Sci 1991;102:67-75.
18. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD: Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992:107:111-121.
19. Ilyas AA, Mithen FA, Dalakas MC, Wargo M, Chen ZW, Bielory L, Cook SD: Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J Neurol Sci 1991;105:108-117.
20. Ilyas AA, Willison HJ, Quarles RH: Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988;23: 440-447.